German Parliamentary Group on AMR
๐๐ฌ ๐๐ซ๐ฎ๐ ๐ซ๐๐ฌ๐ข๐ฌ๐ญ๐๐ง๐๐ ๐๐๐๐๐ฅ๐๐ซ๐๐ญ๐๐ฌ, ๐ญ๐ก๐ ๐ง๐๐๐ ๐๐จ๐ซ ๐ง๐๐ฐ ๐๐ง๐ญ๐ข๐๐ข๐จ๐ญ๐ข๐๐ฌ ๐ก๐๐ฌ ๐ง๐๐ฏ๐๐ซ ๐๐๐๐ง ๐ ๐ซ๐๐๐ญ๐๐ซโ๐๐ง๐ ๐๐๐ซ๐ฆ๐๐ง๐ฒ ๐ข๐ฌ ๐ฌ๐ก๐จ๐ฐ๐ข๐ง๐ ๐ญ๐ก๐ ๐ฉ๐จ๐ฅ๐ข๐ญ๐ข๐๐๐ฅ ๐ฐ๐ข๐ฅ๐ฅ ๐ญ๐จ ๐๐๐ญ
On 24 September 2025, the ๐๐๐ซ๐ฅ๐ข๐๐ฆ๐๐ง๐ญ๐๐ซ๐ฒ ๐๐ซ๐จ๐ฎ๐ฉ ๐จ๐ง ๐๐ง๐ญ๐ข๐ฆ๐ข๐๐ซ๐จ๐๐ข๐๐ฅ ๐๐๐ฌ๐ข๐ฌ๐ญ๐๐ง๐๐ reconvened in Berlin, bringing together parliamentarians and experts to address AMR and the market incentives needed to spur antibiotic innovation.
We were pleased to have Dr. Ralf Sudbrak represent the Hub at the event, contributing valuable insights to this important conversation.
We also congratulate Reps. Stephan Albani (CDU) and Dr. Franziska Kersten (SPD) on their election as chair and co-chair of the Group. Their leadership reflects Germanyโand the governing Grand Coalitionโsโcommitment to advancing solutions to AMR.
Designing incentives for antibiotic development requires courage and bold thinkingโand Germanyโs parliamentarians are stepping up to meet the challenge!
